Publicação
Johnson & Johnson equity research report: research industry & company valuation
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | |
| dc.contributor.advisor | André, Rosário | |
| dc.contributor.author | Bernardo, Emanuel Pinto | |
| dc.date.accessioned | 2026-05-12T09:50:17Z | |
| dc.date.available | 2026-05-12T09:50:17Z | |
| dc.date.issued | 2026-01-20 | |
| dc.date.submitted | 2025-12-17 | |
| dc.description.abstract | Johnson & Johnson, founded in 1886, is a global healthcare leader specializing in pharmaceuticals and medical devices, headquartered in the United States. This report is part of equity research on Johnson & Johnson, and it aims to allow to have a deeper known of the company and his industry. Additionally, a multiples valuation is presented. The overall results of the valuation, taking into account the analysis done, presents a BUY recommendation after obtained a target share price for FY26 of $244.86. | eng |
| dc.identifier.tid | 204240026 | |
| dc.identifier.uri | http://hdl.handle.net/10362/203002 | |
| dc.language.iso | eng | |
| dc.relation | UID/ECO/00124/2013 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Valuation | |
| dc.subject | Discounted cash flow | |
| dc.subject | WACC | |
| dc.subject | Johnson & Johnson | |
| dc.subject | Pharma | |
| dc.title | Johnson & Johnson equity research report: research industry & company valuation | eng |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master Degree in Finance from the NOVA – School of Business and Economics |